The comparison of tumor mutational burden (TMB) in patients of early and late stage lung adenocarcinoma in China.

8520Background: Although PD-L1 positivity improves immunotherapy efficacy, PD-L1 testing alone is insufficient for patient selection in most malignancies. High tumor mutational burden (TMB) is an e...